JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RIGL Financials - Rigel Pharmaceuticals Income & Cash Flow | Ledgeburg
RIGL - Rigel Pharmaceuticals Inc.
USD | NASDAQ | Healthcare
Summary
Summary RIGL Stock
Financials
Financials RIGL Stock
Loading...
Loading...
Income Statement
Income Statement RIGL Stock
Balance Sheet
Balance Sheet RIGL Stock
Cash Flow Statement
Cash Flow Statement RIGL Stock
Loading...
Loading...
Home
Stocks
Rigel Pharmaceuticals Inc. (RIGL)
Financials
Financials of RIGL
Loading...
Loading...
Loading...
Loading...
Revenue
$294.282M
Operating Income
$125.466M
Net Income
$367.024M
Share Count (Basic)
17.987M
Operating Cash Flow
$75.655M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$154.955M
Total Debt
$52.5M
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
80M
100M
Q1 FY25
Q2 FY25
Q3 FY25
Annual
Quarterly
Net Income $USD
-100M
0
100M
200M
300M
400M
Annual
Quarterly
Margins
Gross
Operating
Net
-50%
0%
50%
100%
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
50M
100M
150M
200M
250M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
100%
200%
300%
400%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26